The Motley Fool

Key Data Points

Primary metrics and data points about Acorda Therapeutics, Inc..
Current Price: $30.48
Prev Close: $31.49
Open: $31.33
Bid: $28.00
Ask: $33.50
Day's Range: $30.43 - $31.35
52wk Range: $28.26 - $45.45
Volume: 490,148
Avg Vol 648,220
Market Cap: $1B
P/E (ttm): 92.62
EPS (ttm): $0.34
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Acorda Therapeutics, Inc..

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

ACOR vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Acorda Therapeutics, Inc..
CAPS Rating 4 out of 5
 
218 Outperform
89 Underperform
CAPS All Stars
 
56 Outperform
21 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Cohen, CEO

66% Approve

Based on 9 Ratings

Powered by

More Details about Acorda Therapeutics, Inc.

Primary metrics and data points about Acorda Therapeutics, Inc..